Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
(2011) 159:8518.e1
A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy
Optimised and rapid pre-clinical screening in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Keytruda IP Valuation: What the Franchise Is Actually Worth Keytruda generated $29.5 billion in revenue in fiscal 2024 across more than 40 approved indications
US$ 20.58
US$ 23.84
US$ 24.82
US$ 24.18
US$ 22.93
US$ 22.58
